GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shilpa Medicare Ltd (BOM:530549) » Definitions » COGS-to-Revenue

Shilpa Medicare (BOM:530549) COGS-to-Revenue : 0.32 (As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Shilpa Medicare COGS-to-Revenue?

Shilpa Medicare's Cost of Goods Sold for the three months ended in Mar. 2025 was ₹1,045 Mil. Its Revenue for the three months ended in Mar. 2025 was ₹3,308 Mil.

Shilpa Medicare's COGS to Revenue for the three months ended in Mar. 2025 was 0.32.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shilpa Medicare's Gross Margin % for the three months ended in Mar. 2025 was 68.42%.


Shilpa Medicare COGS-to-Revenue Historical Data

The historical data trend for Shilpa Medicare's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shilpa Medicare COGS-to-Revenue Chart

Shilpa Medicare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.34 0.40 0.35 0.32

Shilpa Medicare Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.32 0.35 0.28 0.32

Shilpa Medicare COGS-to-Revenue Calculation

Shilpa Medicare's COGS to Revenue for the fiscal year that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4103.707 / 12864.141
=0.32

Shilpa Medicare's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1044.699 / 3307.901
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shilpa Medicare  (BOM:530549) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shilpa Medicare's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1044.699 / 3307.901
=68.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Shilpa Medicare COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shilpa Medicare's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shilpa Medicare Business Description

Traded in Other Exchanges
Address
Hyderabad Road, Number 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company's product range includes over 44 oncology and non-oncology APIs. It uses nano and micro technology in its drug identification and formulation. The operating segments of the company are Pharmaceutical products and services, which is the key revenue-generating segment; and Power sales. Geographically, the group derives revenue from India and Outside India, of which prime revenue is generated from India.

Shilpa Medicare Headlines

No Headlines